Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 8, 1999, Pages 1866-1869

  Billington, O J ^a   Mchugh, T D ^a   Gillespie, S H ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; RNA POLYMERASE;

ANTIBIOTIC RESISTANCE; ARTICLE; GENOTYPE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERTANT; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANTIBIOTICS, ANTITUBERCULAR; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, MICROBIAL; MUTATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RIFAMPIN; SELECTION (GENETICS); VARIATION (GENETICS);

EID: 0032876003     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Aber, V. R., and A. J. Nunn. 1978. Chimiotherapie de courte durée de la tuberculose. Facteurs de rechute dans la chimiotherapie de courte durée. Bull. Int. Union Tuberc. 53:276-280.
2. Barnett, M., S. R. M. Bushby, and D. A. Mitchison. 1954. Tubercle bacilli resistant to isoniazid: virulence and response to treatment with isoniazid in guinea pigs. Br. Med. J. 1:128-130.
3. Bjorkman, J., D. Hughes, and D. I. Andersson. 1998. Virulence of antibiotic-resistant Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 95:3949-3953.
4. Blower, S. M., A. R. McLean, T. C. Porco, P. M. Small, P. C. Hopewell, M. A. Sanchez, and A. R. Moss. 1995. The intrinsic transmission dynamics of tuberculosis epidemics. Nat. Med. 1:815-821.
5. Breathnach, A. S., A. de Ruiter, G. M. Holdsworth, N. T. Bateman, D. G. O'Siillivan, P. J. Rees, D. Snashall, H. J. Milburn, B. S. Peters, J. Watson, F. A. Drobniewski, and G. L. French. 1998. An outbreak of multi-drug-resistant tuberculosis in a London teaching hospital. J. Hosp. Infect. 39:111-117.
6. Crane, G. J., S. M. Thomas, and M. E. Jones. 1996. A modified Luria-Delbrück fluctuation assay for estimating and comparing mutation rates. Mutat. Res. 354:171-182.
7. David, H. L. 1970. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl. Microbiol. 20:810-814.
8. Edlin, B. R., J. I. Tokars, M. H. Grieco, J. T. Crawford, J. Williams, E. M. Sordillo, K. R. Ong, J. O. Kilburn, S. W. Dooley, and K. G. Castro. 1992. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. New Engl. J. Med. 326:1514-1521.
9. Gingeras, T. R., G. Ghandour, E. Wang, A. Berno, P. M. Small, F. Drobniewski, D. Alland, E. Desmond, M. Holodniy, and J. Drenkow. 1998. Simultaneous genotyping and species identification using hybridisation pattern recognition analysis of generic mycobacterium DNA arrays. Genome Res. 8:435-448.
10. Jin, D. J., and C. A. Gross. 1988. Mapping and sequence of mutations in Escherichia colt rpoB gene that lead to rifampicin resistance. J. Mol. Biol. 202:45-58.
11. Jin, D. J., W. A. Walter, and C. A. Gross. 1988. Characterisation of the termination phenotypes of rifampicin-resistant mutants. J. Mol. Biol. 202: 245-253.
12. Kyslik, P., M. Dobisova, H. Maresova, and L. Sobotkova. 1993. Plasmid burden in chemostat culture of Escherichia coli - its effect on the selection for overproduces of host enzymes. Biotechnol. Bioeng. 41:325-329.
13. Lee, S. W., and G. Ediin. 1985. Expression of tetracycline resistance in pBR322 derivatives reduces the reproductive fitness of plasmid-containing Escherichia coli. Gene 39:173-180.
14. Lenski, R. E., S. C. Simpson, and T. T. Nguyen. 1994. Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness. J. Bacteriol. 176:3140-3147.
15. Lipsitch, M., and B. R. Levin. 1998. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. Tuber. Lung. Dis. 2:187-199.
16. Miles, A. A., and S. S. Misra. 1938. The estimation of the bacteriocidal power of blood. J. Hyg. Camb. 38:732-749.
17. Mitchison, D. A. 1979. Basic mechanisms of chemotherapy. Chest 76:771-781.
18. Mitchison, D. A. 1998. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int. J. Tuberc. Lung Dis. 2:10-15.
19. Moss, A. R., D. Alland, E. Telzak, D. Hewlett, Jr., V. Sharp, P. Chiliade, V. LaBombardi, D. Kabus, B. Hanna, L. Palumbo, K. Brudney, A. Weltman, K. Stoeckle, K. Chirgwin, M. Simberkof, S. Moghazeh, W. Eisner, M. Lutfey, and B. Kreiswirth. 1997. A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int. J. Tuberc. Lung Dis. 1:115-121.
20. Musser, J. M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:495-514.
21. Ordway, D. J., M. G. Sonnenberg, S. A. Donahue, J. T. Belisle, and I. M. Orme. 1995. Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice. Infect. Immun. 63:741-743.
22. Raviglione, M. C., D. E. Snider, Jr., and A. Kochi. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273:220-226.
23. Schrag, S. J., V. Perrot, and B. R. Levin. 1997. Adaptation to the fitness costs of antibiotic resistance in Escherichia coli. Proc. R. Soc. Lond. B 264:1287-1291.
24. Shimao, T. 1987. Drug resistance in tuberculosis control. Tubercle 68(Suppl. 2):5-18.
25. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
26. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. 1997. Anti-tuberculosis drug resistance in the world. World Health Organization, Geneva, Switzerland.
27. World Health Organization. 1970. A controlled comparison of a twice-weekly and three once-weekly regimens in the initial treatment of pulmonary tuberculosis. Bull. W. H. O. 43:143-206.